All News
ACR20 – Day 1 Report
Friday was the first full day of scientific sessions at the 2020 Virtual ACR/ARP annual meeting. Here are my highlights from day one:
Read Article
Best Imaging Techniques for non ANCA Vasculitis
Large vessel vasculitis (LVV) and CNS vasculitis are rare subsets of vasculitis. The challenges related to these diseases are well known to the rheumatologists who treat around the world.
Read Article
Presenting work by @drdj & I showing "Risk Factors for Lumbar Vertebral #Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip."
🗓️Session: #Epidemiology & #PublicHealth Posters II
⏰1400 GMT/ 0900 ET today!
🗒️Abs#0544
#DEXA #ACR20 @RheumNow
Mrinalini Dey DrMiniDey ( View Tweet)
What do you think? The great debate continues... leave your thoughts in the comment section below! #ACR20 @RheumNow @LCalabreseDO @CCalabreseDO https://t.co/KwQX0XoO93
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Ground-breaking news... the end of #glucocorticoid use in #AAV?
very exciting to reduce GC toxicity! https://t.co/43eCofpOIX
KenWarringtonMD MdWarrington ( View Tweet)
Is it Relapsing #Polychondritis or VEXAS - RP?
Data from @maferradastrong @petercgrayson tell how to tease them apart: #ACR20 #RheumTwitter https://t.co/NwfbqjX5Kw
KenWarringtonMD MdWarrington ( View Tweet)
Use of diagnostic imaging for #GCA is ⬆️
Use of temporal artery biopsy⬇️
data from #MayoClinicRheumatology @garveythomasma1
#acr20 #RheumTwitter https://t.co/kQTg5FTlVq
KenWarringtonMD MdWarrington ( View Tweet)
HCQ Not Associated with QTc Length in SLE and RA Patients: Dr. Janet Pope @Janetbirdope #ACR20
https://t.co/zPIaFIiqr5 https://t.co/Wk8YQpIpo7
Links:
Dr. John Cush RheumNow ( View Tweet)
Great talk #ACR20 @anisha_dua re:monitoring in GCA/TAK
Remember different distributions in GCA/TAK
Slick summary slides with pros/cons of each modality
I find myself picking based on clinical context, suspected involvement/extent, and availability
#ACRambassador https://t.co/euMGbwirG9
Mike Putman EBRheum ( View Tweet)
Talk on collaborative research and team building by @rheum_covid leaders @JYazdanyMD & @philipcrobinson
Dr. Yazdany with an illustration of what the journey might look like for the ECI phase & beyond
#ACR20 #ACRambassador https://t.co/ISNQSrFWws
Rheum Cat rheum_cat ( View Tweet)
SELECT-PsA2 group refractory to prior bDMARD therapy
UPA - useful oral JAKi option in Psoriatic Arthritis
Safety consistent with what we know from RA. More Sfx at 30mg. No clear VTE signal
#ACR20 https://t.co/XpprRprugI
Dr Irwin Lim _connectedcare ( View Tweet)
Cohort study of 186 AI patients from New York => Among patients hospitalized with COVID-19, individuals with autoimmune disease did not have an increased risk of a composite outcome of intensive care unit admission, intubation, or death.
https://t.co/EXGyfrHnjH @jrheum
Dr Philip Robinson philipcrobinson ( View Tweet)
Is It Realistic to Stop Prednisone in Early Rheumatoid Arthritis? A Subanalysis from the BeSt and IMPROVED Studies https://t.co/itrgSeNted #RA #prednisone 18-30% flare ceasing Pred - imi for bridging rather than commence oral! Eular guidelines have a lot to answer for
Peter Nash drpnash ( View Tweet)
Integrated Safety of Filgotinib in Patients with Moderately or Severely Active Rheumatoid Arthritis Receiving Treatment for up to 5.5 Years https://t.co/9YNEGXKoAD #RA #filgotinib low vte & low zoster rates
Peter Nash drpnash ( View Tweet)
Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis https://t.co/T3cXYlCSRC #RA #Upadacitinib 3 yr safety data
Peter Nash drpnash ( View Tweet)
Extreme Fatigue in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms https://t.co/sLGxMwJUhk #SLE #fatigue - fatigue remains a big problem
Peter Nash drpnash ( View Tweet)
Tender non-swollen joints NOT associated with #ultrasound synovitis in DMARD-naïve early #PsoriaticArthritis
👉🏽https://t.co/XcuhlZbpSV
by Dr Dubash @LeedsTeamSpA @LeedsBRC
#ACR20 #0313 https://t.co/TbpxIy83Qt
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
The Prediction of Psoriatic Arthritis Tool (PRESTO) Study – Interim Report https://t.co/zdpk6IvxP0 #PsA # predictors
Peter Nash drpnash ( View Tweet)
Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis https://t.co/hgPDtFRxer #PsA #Guselkumab
Peter Nash drpnash ( View Tweet)
Was delighted to speak to Dr Marwan Bukhari @drdj, Editor-in-Chief of Rheumatology, yesterday at #ACR20. We discussed journal activities over the past year & his personal congress highlights. Watch the video below!
Follow the journal👉@RheumJnl
@RheumNow
https://t.co/C7WW4Ep1Sk
Mrinalini Dey DrMiniDey ( View Tweet)